Literature DB >> 20231821

High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.

Yoko Oyama1, Teruto Hashiguchi, Noboru Taniguchi, Salunya Tancharoen, Tomonori Uchimura, Kamal K Biswas, Ko-Ichi Kawahara, Takao Nitanda, Yoshihisa Umekita, Martin Lotz, Ikuro Maruyama.   

Abstract

Granulomatous nephritis can be triggered by diverse factors and results in kidney failure. However, despite accumulating data about granulomatous inflammation, pathogenetic mechanisms in nephritis remain unclear. The DNA-binding high-mobility group box-1 protein (HMGB1) initiates and propagates inflammation when released by activated macrophages, and functions as an 'alarm cytokine' signaling tissue damage. In this study, we showed elevated HMGB1 expression in renal granulomas in rats with crystal-induced granulomatous nephritis caused by feeding an adenine-rich diet. HMGB1 levels were also raised in urine and serum, as well as in monocyte chemoattractant protein-1 (MCP-1), a mediator of granulomatous inflammation. Injection of HMGB1 worsened renal function and upregulated MCP-1 in rats with crystal-induced granulomatous nephritis. HMGB1 also induced MCP-1 secretion through mitogen-activated protein kinase (MAPK) and phosphoinositide-3-kinase (PI3K) pathways in rat renal tubular epithelial cells in vitro. Hmgb1(+/-) mice with crystal-induced nephritis displayed reduced MCP-1 expression in the kidneys and in urine and the number of macrophages in the kidneys was significantly decreased. We conclude that HMGB1 is a new mediator involved in crystal-induced nephritis that amplifies granulomatous inflammation in a cycle where MCP-1 attracts activated macrophages, resulting in excessive and sustained HMGB1 release. HMGB1 could be a novel target for inhibiting chronic granulomatous diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231821      PMCID: PMC3096665          DOI: 10.1038/labinvest.2010.64

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  49 in total

1.  High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2.

Authors:  Shingo Yamada; Keiichi Inoue; Keiko Yakabe; Hitoshi Imaizumi; Ikuro Maruyama
Journal:  Clin Chem       Date:  2003-09       Impact factor: 8.327

2.  High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine.

Authors:  Noboru Taniguchi; Ko-ichi Kawahara; Kazunori Yone; Teruto Hashiguchi; Munekazu Yamakuchi; Masamichi Goto; Keiichi Inoue; Shingo Yamada; Kosei Ijiri; Shunji Matsunaga; Toshihiro Nakajima; Setsuro Komiya; Ikuro Maruyama
Journal:  Arthritis Rheum       Date:  2003-04

3.  Activation of gene expression in human neutrophils by high mobility group box 1 protein.

Authors:  Jong Sung Park; John Arcaroli; Ho-Kee Yum; Huan Yang; Haichao Wang; Kuang-Yao Yang; Kang-Hyeon Choe; Derek Strassheim; Todd M Pitts; Kevin J Tracey; Edward Abraham
Journal:  Am J Physiol Cell Physiol       Date:  2003-04       Impact factor: 4.249

4.  Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).

Authors:  M D Oldfield; L A Bach; J M Forbes; D Nikolic-Paterson; A McRobert; V Thallas; R C Atkins; T Osicka; G Jerums; M E Cooper
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

5.  HMG-1 as a mediator of acute lung inflammation.

Authors:  E Abraham; J Arcaroli; A Carmody; H Wang; K J Tracey
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

6.  Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells.

Authors:  Carmen Fiuza; Michael Bustin; Shefali Talwar; Margaret Tropea; Eric Gerstenberger; James H Shelhamer; Anthony F Suffredini
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

7.  Associations between toll-like receptors and interleukin-4 in the lungs of patients with tuberculosis.

Authors:  Gael Fenhalls; Ginette R Squires; Liesel Stevens-Muller; Juanita Bezuidenhout; Gillian Amphlett; Ken Duncan; Pauline T Lukey
Journal:  Am J Respir Cell Mol Biol       Date:  2002-12-30       Impact factor: 6.914

8.  Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.

Authors:  Arthur C K Chung; Haiyan Zhang; Yao-Zhong Kong; Jia-Ju Tan; Xiao R Huang; Jeffrey B Kopp; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

9.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.

Authors:  Paola Scaffidi; Tom Misteli; Marco E Bianchi
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

Review 10.  The enigma of sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Peter A Ward
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

View more
  23 in total

1.  High mobility group box protein-1 crossing cell borders may incite an inflammatory "tornado" in renal disease.

Authors:  V Shpacovitch; P R Mertens
Journal:  Int Urol Nephrol       Date:  2010-10-02       Impact factor: 2.370

2.  Urinary MCP-1、HMGB1 increased in calcium nephrolithiasis patients and the influence of hypercalciuria on the production of the two cytokines.

Authors:  Yang Wang; Chun Sun; Chengyang Li; Yaoliang Deng; Guohua Zeng; Zhiwei Tao; Xiang Wang; Xiaofeng Guan; Yutong Zhao
Journal:  Urolithiasis       Date:  2016-07-08       Impact factor: 3.436

Review 3.  The role of necrotic cell death in the pathogenesis of immune mediated nephropathies.

Authors:  Neelakshi R Jog; Roberto Caricchio
Journal:  Clin Immunol       Date:  2014-05-17       Impact factor: 3.969

4.  Hematological, hepatic, and retinal phenotypes in mice deficient for prolyl hydroxylase domain proteins in the liver.

Authors:  Li-Juan Duan; Kotaro Takeda; Guo-Hua Fong
Journal:  Am J Pathol       Date:  2014-02-06       Impact factor: 4.307

5.  Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats.

Authors:  Junichi Tanaka; Yukari Seki; Hiroyasu Ishikura; Maho Tsubota; Fumiko Sekiguchi; Kaoru Yamaguchi; Akira Murai; Takehiro Umemura; Atsufumi Kawabata
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

6.  HMGB1, TGF-β and NF-κB are associated with chronic allograft nephropathy.

Authors:  Shi-Qi Zhao; Zhen-Zhen Xue; Ling-Zhang Wang
Journal:  Exp Ther Med       Date:  2017-10-17       Impact factor: 2.447

7.  The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion.

Authors:  Galina Dvoriantchikova; Eleut Hernandez; Jeff Grant; Andrea Rachelle C Santos; Huan Yang; Dmitry Ivanov
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-09       Impact factor: 4.799

Review 8.  Regulation of wound healing and organ fibrosis by toll-like receptors.

Authors:  Peter Huebener; Robert F Schwabe
Journal:  Biochim Biophys Acta       Date:  2012-12-04

Review 9.  Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases.

Authors:  Irma Garcia-Martinez; Mohamed E Shaker; Wajahat Z Mehal
Journal:  Antioxid Redox Signal       Date:  2015-07-27       Impact factor: 8.401

Review 10.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.